The AI engine Fit Assessment
BetaThe company provides pharma-focused technology solutions for late-phase clinical trials, including RWE, PMS, registries, and modular tools (EDC, CTMS, ePRO, eTMF, eConsent, remote patient monitoring) with regulatory-compliant standards (21 CFR Part 11, ICH-GCP, HIPAA, EU-GDPR, ISO 27001) and India-based, globally scalable operations.
Blurb
HQ Location
Founded
Employees
Total funding raised
Funding Status
Real-World Research. Delivered with Scientific Rigour and Operational Clarity.
At Evalus AI, we help pharmaceutical, biotech, and medical device companies run smarter late-phase studies. Whether it's Real-World Evidence (RWE), PMS, registries, or long-term observational trials, our platform makes complex research simpler, faster, and fully compliant.
Evalus offers a modular suite of validated tools tailored for late-phase research and real-world settings. Our platform enables sponsors to streamline data collection, ensure regulatory alignment, and reduce operational complexity.
Our product includes:
• Electronic Data Capture (EDC)
• Clinical Trial Management System (CTMS)
• Electronic Patient-Reported Outcomes (ePRO)
• Electronic Trial Master File (eTMF)
• eConsent and Remote Patient Monitoring
All modules are built in accordance with 21 CFR Part 11, ICH-GCP, HIPAA, EU-GDPR, and ISO 27001 standards.
Our technology-enabled workflows accelerate data capture and improve data quality while keeping study teams inspection-ready at all times.
Why Choose Evalus?
• Purpose-built for late-phase and RWE studies
• Modular, interoperable digital platform
• Built by regulatory and scientific experts
• Strong compliance foundation
• India-based operations, globally scalable execution
From protocol design to publication, Evalus brings together regulatory precision, scientific clarity, and operational flexibility, helping our clients turn post-approval data into meaningful, measurable insights.